Business Wire · TVTX · October 23, 2026

Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy

Get the app for more

Explore stock news, insights and company research.